Infinant Health
Last verified 2026-06-17. JSON
| Total raised | $39.2M |
|---|---|
| Latest round | Funding round, $39.2M, 2026-06-08 |
| Founded | unknown |
| Headquarters | Sacramento, California |
| Industry | health care |
| Stage | unknown |
| Website | infinanthealth.com |
Infinant Health develops B. infantis probiotic strains that pair with breast milk to build a healthy infant gut microbiome. Its lead product INF108 targets premature infants and the neonatal clinicians caring for them, aiming to prevent necrotizing enterocolitis. Its H5-positive strains digest human milk oligosaccharides far better than rivals.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-06-08 | Funding round | $39.2M | undisclosed |
Detected tech stack
bootstrap 4.6.0, cloudflare, cloudflare bot management, font awesome, google tag manager, headroom.js, hsts, http/3, hubspot cms hub, jquery 3.6.0, jquery cdn, jsdelivr
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $39.2M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $39.2M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | infinanthealth.com, read 2026-06-17 |
| Description | self-reported | infinanthealth.com, read 2026-06-17 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $39.2M, 2026-06-08 → Funding round, $39.2M, 2026-06-08, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $39.2M, 2026-06-08 → Funding round, $39.2M, 2026-06-08 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes